Yanfen Niu

625 total citations
29 papers, 515 citations indexed

About

Yanfen Niu is a scholar working on Molecular Biology, Nephrology and Inorganic Chemistry. According to data from OpenAlex, Yanfen Niu has authored 29 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Nephrology and 7 papers in Inorganic Chemistry. Recurrent topics in Yanfen Niu's work include Gout, Hyperuricemia, Uric Acid (11 papers), Vanadium and Halogenation Chemistry (7 papers) and Inflammasome and immune disorders (4 papers). Yanfen Niu is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (11 papers), Vanadium and Halogenation Chemistry (7 papers) and Inflammasome and immune disorders (4 papers). Yanfen Niu collaborates with scholars based in China and Hong Kong. Yanfen Niu's co-authors include Lihui Gao, Hua Lin, Ling Li, Ming‐Jin Xie, Weiping Liu, Wenyong Xiong, Ji‐Kai Liu, Ling Li, Ling Li and Wei Lu and has published in prestigious journals such as Polymer, American Journal of Physiology-Cell Physiology and European Journal of Pharmacology.

In The Last Decade

Yanfen Niu

28 papers receiving 508 citations

Peers

Countries citing papers authored by Yanfen Niu

Since Specialization

Citations

This map shows the geographic impact of Yanfen Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfen Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfen Niu more than expected).

Fields of papers citing papers by Yanfen Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfen Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfen Niu. The network helps show where Yanfen Niu may publish in the future.

Co-authorship network of co-authors of Yanfen Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfen Niu. A scholar is included among the top collaborators of Yanfen Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfen Niu. Yanfen Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Ginkgetin promotes proliferation and migration of Schwann cells via PIGF/p38 MAPK signaling pathway	Tissue and Cell	Yong Zhang, Yanfen Niu et al.	4
2	Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals	Biological and Pharmaceutical Bulletin	Yanfen Niu, Hongjian Li et al.	1
3	Eriocalyxin B Inhibits Adipogenesis in 3T3-L1 Adipocytes by Cell Cycle Arrest	Natural Products and Bioprospecting	Yanfen Niu, Qian Wang et al.	12
4	Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition	European Journal of Pharmacology	Hua Lin, Cai‐Xia Tu et al.	17
5	Mangiferin alleviates hypertension induced by hyperuricemia via increasing nitric oxide releases	Journal of Pharmacological Sciences	Hua Yang, Wenwei Bai et al.	28
6	Old drug, new indication: Olsalazine sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity	Journal of Pharmacological Sciences	Yanfen Niu, Hongjian Li et al.	12
7	Clerodane Diterpenoids with Anti-hyperglycemic Activity from Tinospora crispa	Natural Products and Bioprospecting	Yuan Gao, Yanfen Niu et al.	20
8	Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity	Pharmaceutical Biology	Yanfen Niu, Jia Liu et al.	26
9	Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents	Natural Products and Bioprospecting	Kun Wei, Gangqiang Wang et al.	25
10	Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental Hyperuricemia	Biological and Pharmaceutical Bulletin	Hua Yang, Lihui Gao et al.	42
11	Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase	Pharmaceutical Biology	Fang Wang, Juming Yan et al.	35
12	Reducing effect of mangiferin on serum uric acid levels in mice	Pharmaceutical Biology	Yanfen Niu, Wei Lu et al.	26
13	A new insulin-enhancing agent: [N,N′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity	European Journal of Medicinal Chemistry	Ming‐Jin Xie, Ling Li et al.	21
14	Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity	European Journal of Medicinal Chemistry	Ming‐Jin Xie, Yanfen Niu et al.	34
15	3,5,2′,4′-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor	Chemico-Biological Interactions	Yanfen Niu, Hua‐Jie Zhu et al.	42
16	Bis(<I>α</I>-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes	Journal of Pharmacy and Pharmacology	Yanfen Niu, Ming‐Jin Xie et al.	4
17	Bis(α-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes	Journal of Pharmacy and Pharmacology	Weiping Liu, Yanfen Niu et al.	11
18	The antilipolytic action of bis(α-furancarboxylato)oxovanadium(IV) in adipocytes	Clinica Chimica Acta	Lihui Gao, Yanfen Niu et al.	10
19	Effects of bis(α-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats	European Journal of Pharmacology	Yanfen Niu, Weiping Liu et al.	22
20	In vivo insulin-mimetic activity of [N,N′-1,3-propyl-bis(salicyladimine)]oxovanadium(IV)	European Journal of Medicinal Chemistry	Ming‐Jin Xie, Guangjun Xu et al.	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact